Here are seven key updates from Centinel Spine in 2025.
1. Centinel Spine’s Prodisc C Vivo and Prodisc C Nova earned the European Union’s Medical Device Regulation certifications.
2. Centinel Spine’s prodisc revenue reached nearly $33 million in the second quarter.
3. The company launched new instrumentation for its prodisc L lumbar disc replacement implant.
4. Centinel Spine’s revenue was more than $32 million during the third quarter, a 42% year-over-year increase.
5. Centinel Spine received FDA premarket approval Oct. 14 for two-level use of its prodisc C Vivo and prodisc C SK cervical disc replacement devices.
6. More than 300,000 of Centinel Spine’s prodisc cervical and lumbar total disc replacement implantations have been performed worldwide. The milestone marks over three decades of clinical use for the company’s prodisc-brand platform, according to a Nov. 13 news release.
7. Centinel Spine earned one- and two-level lumbar disc replacement coverage from the second largest commercial payer in Arizona.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
